AstraZeneca vaccine

ILLUSTRATION: NATHAN LEVASSEUR FOR BLOOMBERG BUSINESSWEEK
Coronavirus chronicle

The world needs the not-for-profit Astrazeneca vaccine, minus the Astrazeneca drama

A healthcare worker shows a vial and a box of the AstraZeneca coronavirus disease (COVID-19) vaccine, as vaccinations resume after a brief pause in their use over concern for possible connection to blood clots, in Turin, Italy, March 19, 2021. REUTERS/Massimo Pinca
Coronavirus chronicle

Questions about AstraZeneca jab linger

A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

US puts J&J in charge of plant that botched Covid vaccine, removes AstraZeneca

The AstraZeneca logo is pictured outside the AstraZeneca office building in Brussels as part of the coronavirus disease (COVID-19) vaccination campaign, Belgium, January 28, 2021. REUTERS/Johanna Geron
Coronavirus chronicle

Dutch temporarily halt AstraZeneca shots for under-60s

A vial with the AstraZeneca's coronavirus disease (COVID-19) vaccine is pictured in Berlin, Germany, March 16, 2021. REUTERS/Hannibal Hanschke
Coronavirus chronicle

Astra vaccine haunts countries that shunned more expensive shots

A vial with the AstraZeneca's coronavirus disease (COVID-19) vaccine is pictured in Berlin, Germany, March 16, 2021. REUTERS/Hannibal Hanschke
Coronavirus chronicle

Germany limits general use of AstraZeneca jabs to people under 60

The production of line for vials of Covishield at the Serum Institute of India Ltd. Hadaspar plant in Pune, India, on Jan. 22. Photographer: Dhiraj Singh/Bloomberg
Coronavirus chronicle

Covax expects full vaccine supplies from India's Serum in May, says Unicef

A healthcare worker shows a vial and a box of the AstraZeneca coronavirus disease (COVID-19) vaccine, as vaccinations resume after a brief pause in their use over concern for possible connection to blood clots, in Turin, Italy, March 19, 2021. REUTERS/Massimo Pinca
Analysis

Missteps could mar long-term credibility of AstraZeneca shot

Vials labelled "Astra Zeneca COVID-19 Coronavirus Vaccine" and a syringe are seen in front of a displayed AstraZeneca logo, in this illustration photo taken March 14, 2021. REUTERS/Dado Ruvic/Illustration/File Photo/File Photo
Coronavirus chronicle

AstraZeneca may have provided incomplete efficacy data from latest Covid-19 trial: NIAID

Vials labelled "Astra Zeneca COVID-19 Coronavirus Vaccine" and a syringe are seen in front of a displayed AstraZeneca logo, in this illustration photo taken March 14, 2021. REUTERS/Dado Ruvic/Illustration/File Photo/File Photo
Coronavirus chronicle

Asia accelerates AstraZeneca Covid-19 vaccine rollouts, even as trust plunges in Europe

A healthcare worker shows a vial and a box of the AstraZeneca coronavirus disease (COVID-19) vaccine, as vaccinations resume after a brief pause in their use over concern for possible connection to blood clots, in Turin, Italy, March 19, 2021. REUTERS/Massimo Pinca
Coronavirus chronicle

AstraZeneca vaccine 79% effective in US trial

The vaccine allegedly "stimulates broad antibody and T cell functions Photo: Medical Xpress
Coronavirus chronicle

Poll points to AstraZeneca concerns as Europe protests grow

AstraZeneca logo is reflected in a drop on a syringe needle in this illustration photo taken March 16, 2021. Picture taken March 16, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Analysis

How worried should we be about reports of blood clots and AstraZeneca's vaccine?